Paediatric Prescription Analysis in a Primary Health Care Institution

Jinish Jose1, Denny Devassykutty2

  • 1Assistant Professor, Department of Pharmacology, Government Medical College , Kottayam, Kerala, India .

Insights

This study analyzed pediatric prescription patterns at a primary care center, finding adherence to WHO guidelines but highlighting the need to reduce antibiotic overuse. This is crucial for combating drug resistance and improving pediatric pharmacotherapy.

Area of Science:

  • Pharmacology
  • Public Health
  • Pediatrics

Background:

  • Limited data exists on pediatric prescription patterns at the primary care level.
  • Recent initiatives include a new prescription format by the Medical Council of India and an antibiotic stewardship program in Kerala.

Purpose of the Study:

  • To analyze pediatric prescription and drug dispensing patterns.
  • To evaluate adherence to World Health Organization (WHO) core drug use indicators.
  • To assess compliance with the Medical Council of India's prescribed format.

Main Methods:

  • A prospective study was conducted over four months at a community health center.
  • Data collected through parent interviews, prescription, and medicine examination.
  • Analysis focused on prescription and dispensing errors using quantitative and qualitative variables.

Main Results:

  • Average of 2.29 drugs prescribed per patient; 98.4% prescribed by generic name.
  • Antibiotic use was frequent (73.18%), with minimal injection use (0.006%).
  • Patient weight recorded in 58.33% of prescriptions; 100% included child details, diagnosis, and doctor's signature.

Conclusions:

  • Pediatric prescription patterns align with WHO standard guidelines.
  • Interventions are necessary to curb antibiotic overprescription.
  • Strengthening antibiotic stewardship is vital to prevent drug-resistant strains.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
628
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
586
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.3K